BRCA2 Gene Mutation tied to Prostae Cancer Progression and Aggressivness
A recent study in Iceland compared survival and disease progression in prostate cancer patients with the Icelandic BRCA2 999del5 founder mutation and those without the mutation. The study evaluated a pool of men with prostate cancer who were related to women who had breast cancer. They found that the gene mutation, BRCA2 999del5 founder mutation, [...]
